Ultimate Neuro Complex
Goals
$32.96 $1.09 per serving
Product analysis
Ultimate Neuro Complex combines ingredients connected with brain signalling and cellular energy. Evidence from people with neurological conditions does not establish dependable improvements in everyday focus or productivity for healthy adults.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality29
Several ingredients have named sources, but the quality of the preparations remains uncertain. Five ingredients lack specified forms, limiting close comparisons.
Ingredient Transparency77
All ingredient amounts are disclosed. Forms are specified for only part of the blend, leaving several preparations unclear.
Value For Money31
The better-defined price comparisons point to limited value for acetyl L-carnitine, vinpocetine and huperzine. The other ingredients do not have enough value information to offset that concern confidently.
Customer Satisfaction73
Customer feedback is positive across several hundred reviews. The review history gives a useful picture of satisfaction without establishing cognitive benefits.
Product Focus52
The blend mainly targets brain function, focus and energy, but expected everyday benefits remain uncertain. Its many ingredients and broad range of uses do not establish improved productivity in healthy adults.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $1.09
- Customer rating
- 4.6 · 360 ratings
Goals
Impact
Highest effect
Huperzine · 100 mcg
Huperzine influences acetylcholine signalling, while acetyl L-carnitine and vinpocetine have links to brain energy or blood-flow mechanisms. Those mechanisms and disease-cohort findings do not establish dependable benefit in healthy adults. Ginkgo has not established routine prevention of cognitive decline, and phosphatidylserine findings do not support reliable general-adult memory improvement.
How this product is rated for Brain Health
Ingredient fit74
Huperzine, acetyl L-carnitine, vinpocetine, ginkgo and phosphatidylserine provide the relevant connection to brain health. The wider formula includes ingredients serving other purposes.
Goal fit
Relevant ingredients share the formula with ingredients for other purposes, reducing its focus on brain health.
Dose adequacy
The five recognised ingredients receive varying partial or full amount recognition.
Pathways80
The saved findings centre on brain energy metabolism and acetylcholine signalling; phosphatidylserine adds a small membrane-related contribution.
Depth
Brain energy metabolism is the strongest assigned route.
Breadth
Acetylcholine signalling and brain energy metabolism reach the coverage threshold; membrane support remains limited.
Evidence88
Huperzine supplies the strongest recognised evidence contribution. Evidence from disease populations does not establish healthy-adult cognitive benefit.
Evidence strength
Huperzine provides the strongest recognised evidence contribution among the ingredients counted here.
Studied preparation
Phosphatidylserine was not recognised as a studied preparation; the other counted ingredients were.
Formulation logic100
The counted ingredients have no unmet partner requirement or matched conflict in the supplied findings. Amount recognition remains distinct from demonstrated cognitive benefit.
Partner coverage
The counted ingredients can contribute independently or have the required partner present.
Conflicts
No configured conflict was matched; this is not a general safety assessment.
Effective doses
All ingredients counted in this finding reach its minimum amount threshold; this does not establish a proven effective dose.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Acetyl L-carnitine relates to mitochondrial energy transport, while NAC and alpha lipoic acid relate to antioxidant defence. Those biological roles and selected clinical findings offer limited support for preserving function in generally healthy adults; phosphatidylserine and ginkgo findings are also inconsistent.
How this product is rated for Longevity
Ingredient fit53
1 assessed ingredient relate to healthy aging, alongside 3 other active ingredients (Chinese Club Moss, Huperzine, Vinpocetine). The product’s broader uses also affect its focus. The assessed amounts provide partial support relative to the saved comparison amounts; any undisclosed amount cannot add dose support.
Goal fit
1 assessed ingredient relate to healthy aging, alongside 3 other active ingredients (Chinese Club Moss, Huperzine, Vinpocetine). The product’s broader uses also affect its focus.
Dose adequacy
The assessed amounts provide partial support relative to the saved comparison amounts; any undisclosed amount cannot add dose support.
Pathways15
The strongest saved support concerns mitochondrial energy production, with partial coverage. No assessed function reaches the saved level for broad coverage.
Depth
The strongest saved support concerns mitochondrial energy production, with partial coverage.
Breadth
No assessed function reaches the saved level for broad coverage.
Evidence63
Acetyl L-Carnitine supplies the strongest saved evidence contribution at an assessed amount. The support remains subject to that ingredient’s preparation and population limits. The assessed ingredients at meaningful amounts match the preparations accepted in the saved assessment.
Evidence strength
Acetyl L-Carnitine supplies the strongest saved evidence contribution at an assessed amount. The support remains subject to that ingredient’s preparation and population limits.
Studied preparation
The assessed ingredients at meaningful amounts match the preparations accepted in the saved assessment.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner present. No configured ingredient conflict was identified in the supplied assessment. 1 of 1 assessed ingredients reach the saved minimum for a meaningful amount.
Partner coverage
The assessed ingredients can contribute independently or have their required partner present.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
1 of 1 assessed ingredients reach the saved minimum for a meaningful amount.
Impact
High effect
Huperzine · 100 mcgAcetyl L-Carnitine · 666 mg
Acetyl L-carnitine relates to cellular energy metabolism, while huperzine inhibits acetylcholine breakdown; their disease-cohort findings do not establish routine benefits for healthy adults. Phosphatidylserine is a membrane component with inconsistent general cognitive evidence. Ginkgo has preliminary preparation-specific attention findings, but its configured amount and extract identity remain unresolved despite a separately retained 80 mg declaration.
How this product is rated for Cognitive Support
Ingredient fit70
Acetyl L-carnitine, huperzine and phosphatidylserine receive amount recognition; ginkgo's configured amount remains unresolved.
Goal fit
Relevant cognitive ingredients are present alongside ingredients serving other purposes.
Dose adequacy
Ginkgo's unresolved configured amount receives no amount recognition; the other assessed ingredients contribute at their declared amounts.
Pathways80
Acetylcholine signaling and cellular energy metabolism are the substantially represented areas.
Depth
Acetylcholine signaling and cellular energy metabolism are the substantially represented areas.
Breadth
Acetylcholine signaling and cellular energy metabolism reach substantial coverage; the other areas do not.
Evidence87
Huperzine leads the saved comparison, but its evidence concerns Alzheimer disease.
Evidence strength
Huperzine leads the saved comparison, but its evidence concerns Alzheimer disease.
Studied preparation
Phosphatidylserine lacks the studied-preparation match; unresolved ginkgo does not enter that amount-qualified comparison.
Formulation logic94
The assessed ingredients need no missing partner, but ginkgo lacks a resolved configured amount. No configured conflict was identified.
Partner coverage
The assessed ingredients work alone or have their required partner; no missing partner was identified.
Conflicts
No configured ingredient conflict was identified.
Effective doses
Acetyl L-carnitine, huperzine and phosphatidylserine meet the saved minimum comparison level; ginkgo's unresolved configured amount does not.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Acetyl L-Carnitine · 666 mgAcetyl L-Carnitine · 666 mgVinpocetine · 10 mgHuperzine · 100 mcg
Acetyl L-carnitine at 666 mg relates to cellular energy processes, while ginkgo, huperzine and vinpocetine relate to cognitive signaling. Evidence from neurological conditions and mixed cognitive findings transfers poorly to everyday work, so improved productivity in healthy adults remains uncertain.
How this product is rated for Productivity Boost
Ingredient fit70
Acetyl L-carnitine, ginkgo, huperzine and vinpocetine provide the main relevant contributions. The relevant amounts provide moderate support relative to the supplied comparison amounts.
Goal fit
Acetyl L-carnitine, ginkgo, huperzine and vinpocetine provide the main relevant contributions.
Dose adequacy
The relevant amounts provide moderate support relative to the supplied comparison amounts.
Pathways18
The strongest relevant route concerns brain energy processes.
Depth
The strongest relevant route concerns brain energy processes.
Breadth
No assessed route reaches the saved threshold for broad coverage.
Evidence60
Acetyl L-Carnitine provides the strongest evidence finding among the relevant ingredients. Benefits for everyday work still depend on the setting and nutritional status. Some preparations match the saved evidence, but huperzine and vinpocetine do not match a studied preparation in those findings.
Evidence strength
Acetyl L-Carnitine provides the strongest evidence finding among the relevant ingredients. Benefits for everyday work still depend on the setting and nutritional status.
Studied preparation
Some preparations match the saved evidence, but huperzine and vinpocetine do not match a studied preparation in those findings.
Formulation logic100
The relevant ingredients can contribute without a required additional partner. No conflicts were identified in the saved assessment.
Partner coverage
The relevant ingredients can contribute without a required additional partner.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All ingredients included in the saved dose check meet its minimum contribution threshold.
Vinpocetine Not classified
No linked studies yet.
Impact
High effect
Acetyl L-Carnitine · 666 mgHuperzine · 100 mcg
Acetyl L-carnitine has roles in energy metabolism and acetylcholine biology. Its saved energy-related recognition does not establish acute focus enhancement in healthy adults. The supplied clinical evidence concerns a different population and longer treatment. Huperzine, ginkgo and vinpocetine likewise lack clear support here for routine healthy-adult focus; the ginkgo amount remains unresolved.
How this product is rated for Mental Focus
Ingredient fit63
The saved findings recognize the main declared ingredients, subject to their amount and preparation limitations.
Goal fit
The saved fit centers on the recognized ingredients, with its broader goal links also affecting the finding.
Dose adequacy
Ginkgo’s unresolved amount reduces the saved amount finding; the other recognized ingredients have disclosed amounts.
Pathways53
The saved pathway coverage is concentrated in the strongest mechanism rather than broad across focus functions.
Depth
The strongest saved pathway is cerebral energy supply; this describes the saved mechanism finding, not demonstrated enhancement.
Breadth
Only one focus pathway reached the saved coverage benchmark, limiting breadth.
Evidence79
Saved evidence recognition must be read alongside the specific preparation and population limitations.
Evidence strength
Acetyl L-carnitine or choline leads the saved recognition, but the supplied context does not establish routine acute focus enhancement.
Studied preparation
Huperzine lacks the studied-preparation match recorded for the other qualifying ingredients.
Formulation logic94
Recognized ingredients meet the recorded partner requirements, with no configured conflict matched.
Partner coverage
No required partner is missing among the ingredients recognized in the saved finding.
Conflicts
No configured conflict was matched in the supplied findings; this is not a general safety assessment.
Effective doses
Ginkgo’s unresolved amount prevents it from meeting the saved amount threshold; the other recognized ingredients meet it.
Huperzine Not classified
No linked studies yet.
Impact
Lower effect
Acetyl L-Carnitine · 666 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Acetyl-L-Carnitine (Acetyl-L-Carnitine HCl) | 666 mg | |
N-Acetyl-L-Cysteine | 400 mg | |
Alpha Lipoic Acid | 200 mg | |
Ginkgo extract (Ginkgo biloba) | 80 mg | |
Phosphatidylserine (Helianthus annuus) | 66 mg | |
Vinpocetine | 10 mg | |
Huperzia serrata extract | 10 mg | |
Huperzine A | 100 mcg |
Huperzine · 100 mcg OverallScore47
A serving supplies 100 mcg of Huperzine A, an amount the evaluation considers targeted. Specific cycling guidance is not established in the available information.
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
Huperzine A is identified, but the plant source and extract standardization are not established in the available information.
Source and Standardization Clarity
Huperzine A is identified, but the plant source and extract standardization are not established in the available information.
Dose, Safety & Label Transparency88
The 100 mcg amount per serving is stated, while specific cycling guidance is not established in the available information.
Huperzine A Dosage Efficacy
The serving provides 100 mcg of Huperzine A, an amount the evaluation considers targeted.
Cycling Guidance and Transparency
The 100 mcg amount is recorded, but specific cycling guidance is not established in the available information.
Value20
Based on the whole-product price, about $1.10 per 100 mcg of Huperzine A is relatively high in the evaluation’s comparison.
Price per 100mcg of Huperzine A
The whole-product price works out to about $1.10 per 100 mcg of Huperzine A, relatively high in the evaluation’s comparison.
Acetyl L-Carnitine (Acetyl-L-Carnitine HCl) · 666 mg OverallScore83
A serving supplies 666 mg of acetyl L-carnitine. Its cost is about $0.82 per 500 mg of acetyl L-carnitine, among the higher costs in the comparison.
How this ingredient is rated
Active Ingredient Quality & Bioavailability94
Acetyl L-carnitine is the recorded carnitine form. The saved facts identify an HCl form; a purity or manufacturing claim is recorded but not independently verified.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is the recorded carnitine form.
Advanced Sourcing and Salt Specificity
The saved facts identify an HCl form; a purity or manufacturing claim is recorded but not independently verified.
Dose, Safety & Label Transparency100
A serving supplies 666 mg of acetyl L-carnitine. Its individual amount is recorded.
Clinical Dosage Efficacy
A serving supplies 666 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The individual amount of acetyl L-carnitine is recorded as 666 mg per serving.
Value25
The cost is about $0.82 per 500 mg of acetyl L-carnitine, among the higher costs in the comparison.
Price per 500mg Acetyl L-Carnitine
The cost is about $0.82 per 500 mg of acetyl L-carnitine, among the higher costs in the comparison.
Vinpocetine · 10 mg OverallScore80
Each serving provides 10 mg of vinpocetine, with the amount recorded separately. At the serving price, 10 mg corresponds to about $1.10 of the whole product.
How this ingredient is rated
Active Ingredient Quality & Bioavailability91
Vinpocetine is identified and its amount is recorded; the evaluation recognizes ordinary excipients.
Vinpocetine Identity and Source
Vinpocetine is identified with an amount of 10 mg per serving.
Excipient and Filler Quality
The evaluation recognizes ordinary excipients; that alone does not characterize the entire ingredient list.
Dose, Safety & Label Transparency100
Each serving contains 10 mg of vinpocetine, with its individual amount recorded.
Vinpocetine Dosage Alignment
The recorded vinpocetine amount is 10 mg per serving.
Proprietary Blend Disclosure
The vinpocetine amount is recorded separately, so it can be identified without estimating a blend share.
Value20
The whole-product serving costs about $1.10, making the vinpocetine amount costly on the evaluation’s price basis.
Cost Efficiency per 10mg Dose
At the serving price, 10 mg of vinpocetine corresponds to about $1.10 of the whole product.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
- Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
- Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
- Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
- [Study of the effects of vinpocetin on cognitive functions].